Wolverine Trading, LLC Regulus Therapeutics Inc. Call Options Transaction History

Wolverine Trading, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.46 - $1.9 $15,768 - $20,520	-10,800 Reduced 44.08%	13,700 $21,000
Q2 2024 Aug 14, 2024	BUY	$1.79 - $2.8 $25,239 - $39,480	14,100 Added 135.58%	24,500 $43,000
Q1 2024 May 15, 2024	BUY	$1.13 - $2.88 $11,751 - $29,952	10,400 New	10,400 $29,000

56.5M

79.3K

20.3K

Ticker RGLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,634,400
Market Cap $22.4M
Description
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.